Comments
Boehringer plans to challenge lung cancer drugs
04.06.2012. | CHICAGO (Reuters) - German drug company Boehringer Ingelheim said on Monday it would test its experimental lung cancer drug directly against AstraZeneca's Iressa and Roche's Tarceva pill, after it showed promise in a late-stage drug trial....
